Structure Therapeutics Inc.
GPCRNasdaqCIK 1888886HealthcareFiscal year ends Dec 31
Reports and events: 60 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-0808:09 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-105688 |
| 2026-08-0616:29 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001104659-26-092057 |
| 2026-08-0616:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-092017 |
| 2026-06-1816:05 ET | 8-K | 5.07 Shareholder vote results | 0001104659-26-075720 |
| 2026-05-0716:45 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-057230 |
| 2026-05-0716:42 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-057226 |
| 2026-04-2316:30 ET | DEF 14A | Proxy statementPeriod 2026-06-17 | 0001104659-26-047740 |
| 2026-04-1506:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-043425 |
| 2026-03-1608:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-028023 |
| 2026-02-2616:40 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104659-26-020562 |
| 2026-02-2616:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-020494 |
| 2026-01-0516:07 ET | 8-K | 1.01 Entry into a material agreement | 0001104659-26-000620 |
| 2025-12-1017:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-120015 |
| 2025-12-0808:47 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-119095 |
| 2025-11-0616:59 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-107829 |
| 2025-11-0616:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-107740 |
| 2025-08-0616:28 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001558370-25-010541 |
| 2025-08-0616:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-074712 |
| 2025-06-2516:15 ET | 8-K | 5.07 Shareholder vote results | 0001104659-25-062576 |
| 2025-05-0816:30 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-006989 |
| 2025-05-0816:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-046149 |
| 2025-04-2416:30 ET | DEF 14A | Proxy statementPeriod 2025-06-23 | 0001104659-25-038675 |
| 2025-02-2716:43 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-001826 |
| 2025-02-2716:38 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-018275 |
| 2024-12-1716:16 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-129378 |
| 2024-11-1316:16 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001558370-24-015531 |
| 2024-11-1316:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-117691 |
| 2024-09-1716:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-100668 |
| 2024-08-2716:16 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-24-093434 |
| 2024-08-0816:23 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001558370-24-011616 |
| 2024-08-0816:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-087275 |
| 2024-06-2717:00 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events | 0001104659-24-075724 |
| 2024-06-0316:59 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-067836 |
| 2024-06-0316:02 ET | S-1 | Registration statement | 0001104659-24-067768 |
| 2024-06-0308:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-067483 |
| 2024-05-0916:56 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001558370-24-007642 |
| 2024-05-0916:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-059329 |
| 2024-04-2516:14 ET | DEF 14A | Proxy statementPeriod 2024-06-25 | 0001104659-24-051972 |
| 2024-03-0809:19 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001558370-24-002791 |
| 2024-03-0808:43 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-032121 |
| 2023-12-1808:28 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-126639 |
| 2023-11-1717:25 ET | S-1 | Registration statement | 0001104659-23-119620 |
| 2023-11-1716:55 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001558370-23-019203 |
| 2023-11-1716:51 ET | 10-Q/A | Quarterly report, amendedPeriod 2023-06-30 | 0001558370-23-019202 |
| 2023-11-1617:13 ET | 10-Q/A | Quarterly report, amendedPeriod 2023-06-30 | 0001558370-23-019165 |
| 2023-11-1417:17 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-118241 |
| 2023-09-2907:50 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-105038 |
| 2023-09-2907:38 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-105027 |
| 2023-08-1016:41 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001558370-23-014524 |
| 2023-08-1016:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-089815 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. Listed shows no prices and gives no investment advice.